(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. Stimulation of cadherin with the NcadFc ligand activates p38 and induces Igf2 expression. (A) Schematic of the N-cadherin/Fc fusion protein (termed NcadFc ligand). (B) Western blot detection of phospho-p38 (pp38), phospho ERK1/2 (pERK1/2), total p38 and total ERK1/2 in myoblasts treated with extract from control Cos7 cells or NcadFc derived from transfected Cos7 cells. (C) p38 MAP kinase activity of myoblasts treated as in B; total p38 levels were determined by western blotting. (D) Northern blot analysis of Igf2 expression in myoblasts treated as in B; ethidium bromide staining of the 18S rRNA bands is shown as a loading control. (E) Igf2 P3 promoter luciferase reporter activity in C2 cells treated as in B. Igf2 promoter activity was expressed as a ratio of luciferase activity of the control secretion treated cells compared with NcadFc-treated cells; ***P<0.001 compared with levels in the control. Western blot analysis of the lysates shows the GFP expression levels.